PRIMARY STUDY
Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats
Key Findings: THCV may have therapeutic potential in reducing nausea.
Type of Study: Animal Study
Study Result: Positive
Study Location(s): Canada
Year of Pub: 2013
Cannabinoids Studied: Tetrahydrocannabivarin (THCV), Cannabidivarin (CBDV)
Phytocannabinoid Source: Unspecified
